ANDROSKAT

This brand name is authorized in Netherlands, United Kingdom

Active ingredients

The drug ANDROSKAT contains a combination of these active pharmaceutical ingredients (APIs):

1 Phentolamine UNII Z468598HBV - PHENTOLAMINE

Phentolamine is a competitive non-selective α1- and α2-adrenergic receptor blocker of relatively short duration of action. It causes vasodilatation and a fall in blood pressure resulting from the blockade of both post-junctional vascular α1- and α2-adrenoceptors. It also antagonises the vasoconstrictor response to noradrenaline and adrenaline infusions. Read about Phentolamine

2 Papaveretum UNII DAA13NKG2Q - PAPAVERINE

Papaveretum is a preparation containing a mixture of hydrochloride salts of opium alkaloids.

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BE30	Combinations	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 350127
Country: NL	Z-Index G-Standaard	Identifier(s): 14077566
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 87580